Determination of 15 Fentanyl-Analogue New Psychoactive Substances in Urine and Blood by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry
摘 要
在尿液或血液样品1.0 mL中加入100 μg·L-1芬太尼-d5内标溶液100 μL和0.1 mol·L-1盐酸溶液4 mL,振荡,离心。上清液过已活化的MCX固相萃取柱,将洗脱液氮吹至近干,残渣用体积比9:1的含0.1%(体积分数)甲酸的5 mmol·L-1乙酸铵缓冲溶液-乙腈混合液溶解,并定容至1 mL,经0.22 μm有机滤膜过滤,采用超高效液相色谱串联质谱法(UHPLC-MS/MS)测定其中15种芬太尼类新精神活性物质的含量。以ACQUITY UPLC BEH C18色谱柱为固定相,以不同体积比的含0.1%甲酸的5 mmol·L-1乙酸铵缓冲溶液-乙腈混合液为流动相进行梯度洗脱。质谱分析中采用电喷雾离子源正离子(ESI+)模式和多反应监测(MRM)模式。结果表明,15种芬太尼类新精神活性物质标准曲线的线性范围均为0.5~50.0 μg·L-1,检出限(3S/N)均为0.1 μg·L-1。对空白样品进行加标回收试验和日内(n=6)、日间(n=6)精密度试验,回收率为81.1%~113%,测定值的相对标准偏差均小于15%。
Abstract
100 μL of 100 μg·L-1 fentanyl-d5 internal standard solution and 4 mL of 0.1 mol·L-1 hydrochloric acid solution were added into 1.0 mL of urine or blood sample. The mixture was oscillated and centrifuged, the supernatant was passed through activated MCX solid phase extraction column, and the eluent was blown to near dryness by nitrogen. The residue was dissolved in a mixture of 5 mmol·L-1 ammonium acetate buffer solution including 0.1% (φ) formic acid and acetonitrile at volume ratio of 9:1, and its volume was made up to 1 mL. The solution was filtered through a 0.22 μm organic filter membrane, and 15 fentanyl-analogue new psychoactive substances were determined by ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) with ACQUITY UPLC BEH C18 column as the stationary phase and the mixtures of 5 mmol·L-1 ammonium acetate buffer solution including 0.1%(φ) formic acid and acetonitrile at different volume ratios as the mobile phase for gradient elution. Electrospray ion source positive ion (ESI+) mode and multiple reaction monitoring (MRM) mode were adopted in MS analysis. As shown by the results, linear ranges of standard curves of 15 fentanyl-analogue new psychoactive substances were 0.5-50.0 μg·L-1, with the same detection limits (3S/N) of 0.1 μg·L-1. Tests for the spiked recovery and inter-day (n=6) and intra-day (n=6) precision were made on blank samples, giving results in the range of 81.1%-113%, with RSDs of the determined values less than 15%.
中图分类号 O657.63 DOI 10.11973/lhjy-hx202209002
所属栏目 试验与研究
基金项目 四川省重点研发项目(2020YFS0471)
收稿日期 2021/8/10
修改稿日期
网络出版日期
作者单位点击查看
备注薛康,工程师,硕士,研究方向为毒品毒物分析
引用该论文: XUE Kang,DENG Huidan,LIU Ruijia,XIAO Yu,MA Li,ZHANG Ge,CHEN Yifeng,HE Jialing,HE Kairong,HU Jiangtao. Determination of 15 Fentanyl-Analogue New Psychoactive Substances in Urine and Blood by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry[J]. Physical Testing and Chemical Analysis part B:Chemical Analysis, 2022, 58(9): 998~1004
薛康,邓惠丹,刘睿佳,肖宇,马丽,张格,陈艺峰,何嘉玲,何开蓉,胡江涛. 超高效液相色谱串联质谱法测定尿液和血液中15种芬太尼类新精神活性物质的含量[J]. 理化检验-化学分册, 2022, 58(9): 998~1004
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
参考文献
【1】STANLEY T H. The history and development of the fentanyl series[J]. Journal of Pain and Symptom Management, 1992,7(3):3-7.
【2】COOREMAN S, DEPREZ C, MARTENS F, et al. A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine[J]. Journal of Separation Science, 2010,33(17/18):2654-2662.
【3】DOTSIKAS Y, LOUKAS Y L, SIAFAKA I. Determination of umbilical cord and maternal plasma concentrations of fentanyl by using novel spectrophotometric and chemiluminescence enzyme immunoassays[J]. Analytica Chimica Acta, 2002,459(2):177-185.
【4】EGAN T D, SHARMA A S, ASHBURN M A, et al. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers[J]. Anesthesiology, 2000,92:665-773.
【5】SZEITZ A, WAYNE R K, HARVEY-CLARK C. Sensitive and selective assay for fentanyl using gas chromatography with mass selective detection[J]. Journal of Chromatography B:Biomedical Sciences and Applications, 1996,675(1):33-42.
【6】郑晓雨,赵彦彪,杨虹贤,等.气相色谱-质谱法和液相色谱-飞行时间质谱法定性分析疑似毒品中的2,5-二甲氧基芬太尼和对甲氧基呋喃芬太尼[J].理化检验-化学分册, 2020,56(8):923-926.
【7】施妍,强火生,刘伟,等.血液中20种芬太尼类物质UPLC-MS/MS法的建立及应用[J].法医学杂志, 2019,35(4):411-418.
【8】刘维,熊歆,张现化,等.液质联用法检测人血浆中舒芬太尼浓度[J].中国临床药理学杂志, 2017,33(9):825-827.
【9】罗耀,张建莹,黄昌雄,等.液相色谱-串联质谱法测定固体及液体药物中27种新型毒品芬太尼类物质[J].分析测试学报, 2020,39(4):427-433.
【10】阎仁信,石建忠,朱国玉.UPLC-MS/MS检验尿液中7种芬太尼类物质[J].中国法医学杂志, 2020,35(3):286-289.
【2】COOREMAN S, DEPREZ C, MARTENS F, et al. A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine[J]. Journal of Separation Science, 2010,33(17/18):2654-2662.
【3】DOTSIKAS Y, LOUKAS Y L, SIAFAKA I. Determination of umbilical cord and maternal plasma concentrations of fentanyl by using novel spectrophotometric and chemiluminescence enzyme immunoassays[J]. Analytica Chimica Acta, 2002,459(2):177-185.
【4】EGAN T D, SHARMA A S, ASHBURN M A, et al. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers[J]. Anesthesiology, 2000,92:665-773.
【5】SZEITZ A, WAYNE R K, HARVEY-CLARK C. Sensitive and selective assay for fentanyl using gas chromatography with mass selective detection[J]. Journal of Chromatography B:Biomedical Sciences and Applications, 1996,675(1):33-42.
【6】郑晓雨,赵彦彪,杨虹贤,等.气相色谱-质谱法和液相色谱-飞行时间质谱法定性分析疑似毒品中的2,5-二甲氧基芬太尼和对甲氧基呋喃芬太尼[J].理化检验-化学分册, 2020,56(8):923-926.
【7】施妍,强火生,刘伟,等.血液中20种芬太尼类物质UPLC-MS/MS法的建立及应用[J].法医学杂志, 2019,35(4):411-418.
【8】刘维,熊歆,张现化,等.液质联用法检测人血浆中舒芬太尼浓度[J].中国临床药理学杂志, 2017,33(9):825-827.
【9】罗耀,张建莹,黄昌雄,等.液相色谱-串联质谱法测定固体及液体药物中27种新型毒品芬太尼类物质[J].分析测试学报, 2020,39(4):427-433.
【10】阎仁信,石建忠,朱国玉.UPLC-MS/MS检验尿液中7种芬太尼类物质[J].中国法医学杂志, 2020,35(3):286-289.
相关信息